1. Home
  2. ZLAB vs NSA Comparison

ZLAB vs NSA Comparison

Compare ZLAB & NSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • NSA
  • Stock Information
  • Founded
  • ZLAB 2013
  • NSA 2013
  • Country
  • ZLAB China
  • NSA United States
  • Employees
  • ZLAB N/A
  • NSA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • NSA Real Estate Investment Trusts
  • Sector
  • ZLAB Health Care
  • NSA Real Estate
  • Exchange
  • ZLAB Nasdaq
  • NSA Nasdaq
  • Market Cap
  • ZLAB 3.0B
  • NSA 3.2B
  • IPO Year
  • ZLAB 2017
  • NSA 2015
  • Fundamental
  • Price
  • ZLAB $26.05
  • NSA $36.61
  • Analyst Decision
  • ZLAB Strong Buy
  • NSA Hold
  • Analyst Count
  • ZLAB 3
  • NSA 9
  • Target Price
  • ZLAB $55.00
  • NSA $43.06
  • AVG Volume (30 Days)
  • ZLAB 482.4K
  • NSA 664.3K
  • Earning Date
  • ZLAB 02-25-2025
  • NSA 02-26-2025
  • Dividend Yield
  • ZLAB N/A
  • NSA 6.23%
  • EPS Growth
  • ZLAB N/A
  • NSA 71.81
  • EPS
  • ZLAB N/A
  • NSA 1.83
  • Revenue
  • ZLAB $355,748,000.00
  • NSA $786,922,000.00
  • Revenue This Year
  • ZLAB $49.04
  • NSA N/A
  • Revenue Next Year
  • ZLAB $46.70
  • NSA $1.28
  • P/E Ratio
  • ZLAB N/A
  • NSA $20.03
  • Revenue Growth
  • ZLAB 35.01
  • NSA N/A
  • 52 Week Low
  • ZLAB $13.48
  • NSA $34.50
  • 52 Week High
  • ZLAB $36.60
  • NSA $49.44
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 50.14
  • NSA 35.05
  • Support Level
  • ZLAB $23.82
  • NSA $35.67
  • Resistance Level
  • ZLAB $25.64
  • NSA $37.25
  • Average True Range (ATR)
  • ZLAB 1.24
  • NSA 0.92
  • MACD
  • ZLAB 0.06
  • NSA 0.10
  • Stochastic Oscillator
  • ZLAB 64.45
  • NSA 35.07

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

About NSA National Storage Affiliates Trust of Beneficial Interest

National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, Northwest and Move It brands.

Share on Social Networks: